PATENT CLAIM ANALYSIS

Application Number: 15765816
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "552000"]

Abstract:
This invention relates to treating and preventing urinary tract infections. Glycerol monolaurate (GML) and/or GML-related compositions together with suitable accelerants in gel-based formulation may be used to treat urinary tract infections that may be generally diagnosed, for example, in women, catheterized patients and elderly individuals. Such a gel-based formulation kills, or inhibits the growth of, one or more pathogenic microorganisms that cause urinary tract infections.

Claim (Index 26):
The gel-based formulation of  claim 23 , further comprising a cellulose derivative selected from the group consisting of hydroxyethyl and hydroxypropyl cellulose

Metadata:
- Claim Count in Document: 11.0
- Percentile: 91.0
- Lexical Diversity: 1.38889
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13866722', '15266165', '15266388', '15171646', '12810654']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7016254016530319
- 35 USC 102 Novelty (BERT): 0.5101632049328
- Combined Prediction Score: 0.6824791819810087
- Mean Citation Score: 192.117736
- Max Citation Score: 239.31462
- Similarity Product: 160.06082044150472

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test